Antibody discovery with LabGenius' James Field
Jun 06, 2024•43 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery.
Find out more about Labgenius here and follow them on LinkedIn
For the best experience, listen in Metacast app for iOS or Android